Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Marie Skłodowska-Curie Action · Running

BENEFITTING Haplotype-based inference of hidden structure in the human genome

Coordinator
The Chancellor, Masters and Scholars of the University of Oxford, United Kingdom
Runs
1 November 2026 to 31 October 2028
Status
Running
EU funding
€276k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101268119

What the project is doing

In the project's own words, from its summary on CORDIS.

The rapid emergence of high-throughput genomic technologies—such as low-coverage sequencing (LCS), ancient DNA (aDNA), and long-read sequencing (LRS)—offers unprecedented opportunities to explore human evolutionary history and advance medical genetics. However, the full potential of these data remains underexploited due to analytical and methodological limitations: for example, low coverage aDNA (<0.5x) is typically excluded ancestral recombination graph (ARG) analyses, while low structural variant (SV) genotyping accuracy and the lack of reliable imputation panels limit population-scale association studies.

This project proposes the development of two innovative haplotype-based statistical methods to overcome these barriers and unlock novel biological insights. First, I will establish a unified framework that integrates ARG construction with genotype imputation, enabling robust large-scale genealogical and demographic analyses of both modern and ancient low-coverage genomes. Second, I will develop a probabilistic haplotype-based approach for structural variant (SV) genotyping and imputation with long-read sequencing data, applying it to large population cohorts.

These methods will be validated on cutting-edge resources, including the UK Biobank and the Allen Ancient DNA Resource, and disseminated through open-source software. By bridging methodological gaps in aDNA and SV analyses, this project will deliver tools for demography inference using ARGs, SV-informed trait mapping, and the integration of diverse genomic data in population and medical genomics. The first application of the tools will have profound impacts.

The unlocked high-resolution human history will contribute to public discourse on the definition and biomedical use of genetic ancestry. Discoveries of disease-associated SVs and underlying biological mechanisms will inform drug development, personalized treatment, and supporting industrial innovation.

Topics

Who is involved

OrganisationCityCountryRole
The Chancellor, Masters and Scholars of the University of OxfordOxfordUnited KingdomCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI